| | SLE/TNT: LJP 394 Improves/Sustains Health-Related Quality of Life in Lupus Renal Disease (Site not responding. Last check: ) |
 | | And, although this is the first health-related quality of life evaluation of LJP 394, the longitudinal improvement is consistent with other reported benefits -- the delay of renal flares and the delay in treatments with high-dose corticosteroids and/or cyclophosphamide. |
 | | As expected, at the beginning of the study, the mean scores for all patients were significantly lower in all domains compared with normal individuals in the U.S. of similar age and sex, indicating that these lupus patients' perception of their quality of life was poor. |
 | | The objective of the Phase II/III clinical trial was to evaluate the ability of LJP 394 to increase time to renal flare in lupus patients with a history of renal disease. |
| www.pslgroup.com /dg/211D92.htm (753 words) |